SCHEMBL14724332

SCHEMBL14724332

N#CCCSC(=S)NCCc1cccnc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 1/20 0.45
BCL6 P41182 1/20 0.44
ALDH1A1 P00352 3/20 0.43
PKM P14618 3/20 0.43
NLRP3 Q96P20 1/20 0.43
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
CHRNA7 P36544 1/20 0.41
CTSL P07711 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12284781 0.93 IDO1 (0.43) IDO1SMN1; SMN2HTTALDH1A1PKM
SCHEMBL14724326 0.87 HTT (0.60) SMN1; SMN2HTTALDH1A1PKMCTSL
SCHEMBL2930645 0.77 SMN1; SMN2 (0.73) IDO1SMN1; SMN2HTTBCL6ALDH1A1
SCHEMBL14715011 0.76 LMNA (0.47) SMN1; SMN2BCL6ALDH1A1PKMKDM4E
SCHEMBL17056132 0.74 MAPT (0.47) SMN1; SMN2ALDH1A1PKMKDM4EMAPT
SCHEMBL14985815 0.73 HTT (0.38) SMN1; SMN2HTTALDH1A1PKMKDM4E
SCHEMBL14982897 0.73 CA9 (0.42) SMN1; SMN2HTTALDH1A1PKMKDM4E
SCHEMBL255080 0.73 CHRNA7 (0.57) CHRNA7MEN1KMT2A
SCHEMBL14715028 0.72 CHRNB2 (0.47) SMN1; SMN2HTTALDH1A1KDM4EMAPT
SCHEMBL525715 0.72 ALDH1A1 (0.56) IDO1SMN1; SMN2HTTBCL6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF PEKING UNIVERSITY (CN) 2013-05-30 US disclosed
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF PEKING UNIVERSITY (CN) 2013-05-30 US disclosed
EP-2562157-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF Peking University (CN) 2013-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130136794-A1 HETEROARYL (ALKYL) DITHIOCARBAMATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF LTK, ERBB2, ABL1 IDO1 2550/4885SMN1; SMN2 4595/4885HTT 1099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.